Britain to fund prostate cancer pill in U-turn – YAHOO!

LONDON (Reuters) – Britain’s drug watchdog has reversed a controversial decision not to fund a new prostate cancer pill that was developed in the country after maker Johnson & Johnson agreed a new discount on supplies to the UK state healthcare service.

Posted in Uncategorized